Skip to main content
Equibles

Russell Investments Group, Ltd.

Position in RNA — Atrium Therapeutics, Inc.

CIK 1692234 Seattle, WA
Back to RNA Full portfolio

Position in RNA

as of Jun 30, 2026 · filed Aug 6, 2026
Position Value
$60,185
+$8,859 QoQ
Shares Held
4,475
+16.6% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 154 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 97% Shared 0% None 3%

Common Shares in RNA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. RNA ranks #223 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 336,990 $167,393,033
2 REGN
Regeneron Pharmaceuticals, Inc.
 230,151 $143,508,345
3 RPRX
Royalty Pharma plc
 1,694,250 $94,996,587
4 INCY
Incyte Corp
 425,616 $48,247,822
5 ALNY
Alnylam Pharmaceuticals, Inc.
 158,228 $47,631,369
6 BMRN
Biomarin Pharmaceutical Inc
 783,148 $44,811,725
7 LGND
Ligand Pharmaceuticals Inc
 120,304 $38,026,888
8 PTCT
Ptc Therapeutics, Inc.
 418,025 $34,098,295

All Filings in RNA

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $60,185 4,475
2026-03-31 $51,326 3,839